Norwegian Finans Holding ASA
Bank Norwegian AS refers to the announcement on 8 March 2021. The bank has today issued two senior preferred bonds denominated in NOK and SEK with the following terms:
NOK 700 million with a 4 year tenor with a call option for the issuer after 3 years and quarterly thereafter, with a coupon equal to 3 months NIBOR + 1.45% p.a.
SEK 300 million with a 4 year tenor with a call option for the issuer after 3 years and quarterly thereafter, with a coupon equal to 3 months STIBOR + 1.40% p.a.
The settlement date for both issues is 18 March 2021. The bonds are issued under Bank Norwegian’s EMTN programme, and will be applied for listing on Oslo Stock Exchange.
SpareBank 1 Markets and Swedbank acted as joint lead managers.
Contact persons:
CFO Klara-Lise Aasen; phone +47 47 63 55 83; kaa@banknorwegian.no
Head of treasury Mats Benserud; phone +47 95 89 15 39; mbe@banknorwegian.no
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Global Allergy and Airways Patient Platform26.10.2025 20:17:14 CET | Press release
New Global Coalition Launches to Address the Hidden Threat of RSV in Adults
ARETI International Group26.10.2025 18:41:15 CET | Press release
ARETI International Group, Headed by Igor Makarov, Partners with INEX CLUB to Support the Mayflower Gran Prix Cyprus 2025
Novartis Pharma AG26.10.2025 18:00:00 CET | Press release
Novartis agrees to acquire Avidity Biosciences, an innovator in RNA therapeutics, strengthening its late-stage neuroscience pipeline
mediCAD Hectec GmbH26.10.2025 12:45:00 CET | Press release
mediCAD® 8 Revolutionizes Orthopedic and Trauma Planning with Intelligent AI Integration
Novartis Pharma AG25.10.2025 17:00:00 CEST | Press release
Novartis showcases significant immunology advancements in ACR congress with new data in complex autoimmune diseases
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
